Back to Authors

Hugar, Lee A.

0000-0003-0004-6001

A5088297747 | I4210104643

Mayo Clinic

Lexington Medical Center

Citations 2

Primary Palliative Care in Urology: Quality Improvement Summit 2021-2022

Urology Practice | March 7, 2024 | Volume: 11 | Issue: 3 | Pages: 529-536

10.1097/upj.0000000000000538 | PMID 38451199

Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer

Journal of Clinical Oncology | September 1, 2023 | Volume: 41 | Issue: 34 | Pages: 5296-5305

10.1200/jco.23.00443 | PMID 37656935

What is the role of pcRPLND in men with retroperitoneal vital cancer after first-line chemotherapy? This question arises because of the potential predictive value of miR371 in identifying residual cancer even before pcRPLND! @cdfankhauser shared data within a multicenter cohort study redefining future practice in the miR371 era.